Use of stem cells in non-alcoholic fatty liver disease
Stem cell therapy has emerged as a promising treatment option for non-alcoholic fatty liver disease (NAFLD). Preclinical studies have demonstrated the potential of stem cells to differentiate into hepatocytes and promote liver regeneration. Clinical trials are currently underway to investigate the safety and efficacy of stem cell therapy in NAFLD patients.